Amussen Hunsaker Associates LLC Intercept Pharmaceuticals, Inc. Transaction History

Amussen Hunsaker Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 19, 2019	SELL	$85.79 - $126.46 $46,240 - $68,161	-539 Closed	0 $0
Q3 2018 Nov 16, 2018	SELL	$88.49 - $127.55 $8,141 - $11,734	-92 Reduced 14.58%	539 $52,000
Q2 2018 Aug 16, 2018	BUY	$60.0 - $85.67 $37,860 - $54,057	631 New	631 $53,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.